PDL BioPharma, Inc. Amortization
PDL BioPharma, Inc. reported Amortization of $7.61 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2019-03-15
- PDL BioPharma, Inc. amortization for fiscal 2018 was $7.61M, a 31.06% decline from fiscal 2017.
- PDL BioPharma, Inc. amortization for fiscal 2017 was $11.04M, a 18.07% decline from fiscal 2016.
- PDL BioPharma, Inc. amortization for fiscal 2016 was $13.47M, a 13.66% decline from fiscal 2015.
- PDL BioPharma, Inc. amortization for fiscal 2015 was $15.60M.
| Period end | Amortization 12 month |
|---|---|
| 2018-12-31 | $7.61M 10-K · filed 2019-03-15 |
| 2017-12-31 | $11.04M 10-K · filed 2019-03-15 |
| 2016-12-31 | $13.47M 10-K · filed 2018-03-16 |
| 2015-12-31 | $15.60M 10-K · filed 2017-03-01 |